Financhill
Sell
31

QTRX Quote, Financials, Valuation and Earnings

Last price:
$5.75
Seasonality move :
-17.99%
Day range:
$5.75 - $6.18
52-week range:
$4.05 - $8.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.85x
P/B ratio:
0.88x
Volume:
230.2K
Avg. volume:
683.6K
1-year change:
-23.82%
Market cap:
$277.9M
Revenue:
$137.4M
EPS (TTM):
-$2.33

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
QTRX
Quanterix Corp.
$38M -$0.69 20.97% -- $7.33
BIO
Bio-Rad Laboratories, Inc.
$687.7M $2.70 0.05% -13.46% $324.00
BRKR
Bruker Corp.
$963.8M $0.65 -1.03% 101.14% $48.43
HOLX
Hologic, Inc.
$1.1B $1.10 2.94% 26.98% $76.60
NUWE
Nuwellis, Inc.
$2.3M -- 9.98% -- $13.00
VREX
Varex Imaging Corp.
$207.8M $0.13 1.89% 55.79% $18.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
QTRX
Quanterix Corp.
$5.95 $7.33 $277.9M -- $0.00 0% 1.85x
BIO
Bio-Rad Laboratories, Inc.
$271.90 $324.00 $7.3B 9.74x $0.00 0% 2.87x
BRKR
Bruker Corp.
$38.76 $48.43 $5.9B 77.08x $0.05 0.52% 1.71x
HOLX
Hologic, Inc.
$75.14 $76.60 $16.8B 31.18x $0.00 0% 4.11x
NUWE
Nuwellis, Inc.
$1.87 $13.00 $13M -- $0.00 0% 0.50x
VREX
Varex Imaging Corp.
$13.75 $18.00 $576.4M 17.58x $0.00 0% 0.71x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
QTRX
Quanterix Corp.
11.31% 2.005 15.83% 2.19x
BIO
Bio-Rad Laboratories, Inc.
15.67% 1.271 16.94% 3.89x
BRKR
Bruker Corp.
43.04% 1.053 25.98% 0.66x
HOLX
Hologic, Inc.
32.46% 1.161 15.17% 3.14x
NUWE
Nuwellis, Inc.
8.91% -2.261 1.64% 1.20x
VREX
Varex Imaging Corp.
45.7% 1.770 79.9% 1.69x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
QTRX
Quanterix Corp.
$17.2M -$30.2M -26.87% -30.04% -74.94% -$41.9M
BIO
Bio-Rad Laboratories, Inc.
$344.8M $61.9M 9.16% 10.99% 8.93% $119.1M
BRKR
Bruker Corp.
$449.6M $93.9M -0.2% -0.39% 9.61% $207.2M
HOLX
Hologic, Inc.
$584.1M $240.9M 7.3% 11.09% 22.99% $194.8M
NUWE
Nuwellis, Inc.
$1.4M -$2.7M -773.58% -1004.06% -121.65% -$3.2M
VREX
Varex Imaging Corp.
$69.8M $15.4M -6.79% -13.14% 7.35% -$26.8M

Quanterix Corp. vs. Competitors

  • Which has Higher Returns QTRX or BIO?

    Bio-Rad Laboratories, Inc. has a net margin of -83.31% compared to Quanterix Corp.'s net margin of -52.36%. Quanterix Corp.'s return on equity of -30.04% beat Bio-Rad Laboratories, Inc.'s return on equity of 10.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix Corp.
    42.77% -$0.73 $354.7M
    BIO
    Bio-Rad Laboratories, Inc.
    49.74% $26.65 $8.8B
  • What do Analysts Say About QTRX or BIO?

    Quanterix Corp. has a consensus price target of $7.33, signalling upside risk potential of 23.25%. On the other hand Bio-Rad Laboratories, Inc. has an analysts' consensus of $324.00 which suggests that it could grow by 19.16%. Given that Quanterix Corp. has higher upside potential than Bio-Rad Laboratories, Inc., analysts believe Quanterix Corp. is more attractive than Bio-Rad Laboratories, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix Corp.
    0 3 0
    BIO
    Bio-Rad Laboratories, Inc.
    2 2 0
  • Is QTRX or BIO More Risky?

    Quanterix Corp. has a beta of 1.094, which suggesting that the stock is 9.406% more volatile than S&P 500. In comparison Bio-Rad Laboratories, Inc. has a beta of 1.180, suggesting its more volatile than the S&P 500 by 18.018%.

  • Which is a Better Dividend Stock QTRX or BIO?

    Quanterix Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bio-Rad Laboratories, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix Corp. pays -- of its earnings as a dividend. Bio-Rad Laboratories, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or BIO?

    Quanterix Corp. quarterly revenues are $40.2M, which are smaller than Bio-Rad Laboratories, Inc. quarterly revenues of $693.2M. Quanterix Corp.'s net income of -$33.5M is lower than Bio-Rad Laboratories, Inc.'s net income of $720M. Notably, Quanterix Corp.'s price-to-earnings ratio is -- while Bio-Rad Laboratories, Inc.'s PE ratio is 9.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix Corp. is 1.85x versus 2.87x for Bio-Rad Laboratories, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix Corp.
    1.85x -- $40.2M -$33.5M
    BIO
    Bio-Rad Laboratories, Inc.
    2.87x 9.74x $693.2M $720M
  • Which has Higher Returns QTRX or BRKR?

    Bruker Corp. has a net margin of -83.31% compared to Quanterix Corp.'s net margin of 2.99%. Quanterix Corp.'s return on equity of -30.04% beat Bruker Corp.'s return on equity of -0.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix Corp.
    42.77% -$0.73 $354.7M
    BRKR
    Bruker Corp.
    46.01% $0.10 $4.4B
  • What do Analysts Say About QTRX or BRKR?

    Quanterix Corp. has a consensus price target of $7.33, signalling upside risk potential of 23.25%. On the other hand Bruker Corp. has an analysts' consensus of $48.43 which suggests that it could grow by 24.95%. Given that Bruker Corp. has higher upside potential than Quanterix Corp., analysts believe Bruker Corp. is more attractive than Quanterix Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix Corp.
    0 3 0
    BRKR
    Bruker Corp.
    7 5 1
  • Is QTRX or BRKR More Risky?

    Quanterix Corp. has a beta of 1.094, which suggesting that the stock is 9.406% more volatile than S&P 500. In comparison Bruker Corp. has a beta of 1.186, suggesting its more volatile than the S&P 500 by 18.621%.

  • Which is a Better Dividend Stock QTRX or BRKR?

    Quanterix Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bruker Corp. offers a yield of 0.52% to investors and pays a quarterly dividend of $0.05 per share. Quanterix Corp. pays -- of its earnings as a dividend. Bruker Corp. pays out 26.44% of its earnings as a dividend. Bruker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios QTRX or BRKR?

    Quanterix Corp. quarterly revenues are $40.2M, which are smaller than Bruker Corp. quarterly revenues of $977.2M. Quanterix Corp.'s net income of -$33.5M is lower than Bruker Corp.'s net income of $29.2M. Notably, Quanterix Corp.'s price-to-earnings ratio is -- while Bruker Corp.'s PE ratio is 77.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix Corp. is 1.85x versus 1.71x for Bruker Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix Corp.
    1.85x -- $40.2M -$33.5M
    BRKR
    Bruker Corp.
    1.71x 77.08x $977.2M $29.2M
  • Which has Higher Returns QTRX or HOLX?

    Hologic, Inc. has a net margin of -83.31% compared to Quanterix Corp.'s net margin of 17.09%. Quanterix Corp.'s return on equity of -30.04% beat Hologic, Inc.'s return on equity of 11.09%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix Corp.
    42.77% -$0.73 $354.7M
    HOLX
    Hologic, Inc.
    55.75% $0.79 $7.8B
  • What do Analysts Say About QTRX or HOLX?

    Quanterix Corp. has a consensus price target of $7.33, signalling upside risk potential of 23.25%. On the other hand Hologic, Inc. has an analysts' consensus of $76.60 which suggests that it could grow by 1.94%. Given that Quanterix Corp. has higher upside potential than Hologic, Inc., analysts believe Quanterix Corp. is more attractive than Hologic, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix Corp.
    0 3 0
    HOLX
    Hologic, Inc.
    0 16 0
  • Is QTRX or HOLX More Risky?

    Quanterix Corp. has a beta of 1.094, which suggesting that the stock is 9.406% more volatile than S&P 500. In comparison Hologic, Inc. has a beta of 0.717, suggesting its less volatile than the S&P 500 by 28.288%.

  • Which is a Better Dividend Stock QTRX or HOLX?

    Quanterix Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix Corp. pays -- of its earnings as a dividend. Hologic, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or HOLX?

    Quanterix Corp. quarterly revenues are $40.2M, which are smaller than Hologic, Inc. quarterly revenues of $1B. Quanterix Corp.'s net income of -$33.5M is lower than Hologic, Inc.'s net income of $179.1M. Notably, Quanterix Corp.'s price-to-earnings ratio is -- while Hologic, Inc.'s PE ratio is 31.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix Corp. is 1.85x versus 4.11x for Hologic, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix Corp.
    1.85x -- $40.2M -$33.5M
    HOLX
    Hologic, Inc.
    4.11x 31.18x $1B $179.1M
  • Which has Higher Returns QTRX or NUWE?

    Nuwellis, Inc. has a net margin of -83.31% compared to Quanterix Corp.'s net margin of 21.11%. Quanterix Corp.'s return on equity of -30.04% beat Nuwellis, Inc.'s return on equity of -1004.06%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix Corp.
    42.77% -$0.73 $354.7M
    NUWE
    Nuwellis, Inc.
    65.18% $0.56 $4.3M
  • What do Analysts Say About QTRX or NUWE?

    Quanterix Corp. has a consensus price target of $7.33, signalling upside risk potential of 23.25%. On the other hand Nuwellis, Inc. has an analysts' consensus of $13.00 which suggests that it could grow by 24605.91%. Given that Nuwellis, Inc. has higher upside potential than Quanterix Corp., analysts believe Nuwellis, Inc. is more attractive than Quanterix Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix Corp.
    0 3 0
    NUWE
    Nuwellis, Inc.
    0 1 0
  • Is QTRX or NUWE More Risky?

    Quanterix Corp. has a beta of 1.094, which suggesting that the stock is 9.406% more volatile than S&P 500. In comparison Nuwellis, Inc. has a beta of -0.106, suggesting its less volatile than the S&P 500 by 110.586%.

  • Which is a Better Dividend Stock QTRX or NUWE?

    Quanterix Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix Corp. pays -- of its earnings as a dividend. Nuwellis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or NUWE?

    Quanterix Corp. quarterly revenues are $40.2M, which are larger than Nuwellis, Inc. quarterly revenues of $2.2M. Quanterix Corp.'s net income of -$33.5M is lower than Nuwellis, Inc.'s net income of $468K. Notably, Quanterix Corp.'s price-to-earnings ratio is -- while Nuwellis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix Corp. is 1.85x versus 0.50x for Nuwellis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix Corp.
    1.85x -- $40.2M -$33.5M
    NUWE
    Nuwellis, Inc.
    0.50x -- $2.2M $468K
  • Which has Higher Returns QTRX or VREX?

    Varex Imaging Corp. has a net margin of -83.31% compared to Quanterix Corp.'s net margin of 1.15%. Quanterix Corp.'s return on equity of -30.04% beat Varex Imaging Corp.'s return on equity of -13.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix Corp.
    42.77% -$0.73 $354.7M
    VREX
    Varex Imaging Corp.
    33.3% $0.05 $892.1M
  • What do Analysts Say About QTRX or VREX?

    Quanterix Corp. has a consensus price target of $7.33, signalling upside risk potential of 23.25%. On the other hand Varex Imaging Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 30.91%. Given that Varex Imaging Corp. has higher upside potential than Quanterix Corp., analysts believe Varex Imaging Corp. is more attractive than Quanterix Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix Corp.
    0 3 0
    VREX
    Varex Imaging Corp.
    3 1 0
  • Is QTRX or VREX More Risky?

    Quanterix Corp. has a beta of 1.094, which suggesting that the stock is 9.406% more volatile than S&P 500. In comparison Varex Imaging Corp. has a beta of 0.901, suggesting its less volatile than the S&P 500 by 9.934%.

  • Which is a Better Dividend Stock QTRX or VREX?

    Quanterix Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix Corp. pays -- of its earnings as a dividend. Varex Imaging Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or VREX?

    Quanterix Corp. quarterly revenues are $40.2M, which are smaller than Varex Imaging Corp. quarterly revenues of $209.6M. Quanterix Corp.'s net income of -$33.5M is lower than Varex Imaging Corp.'s net income of $2.4M. Notably, Quanterix Corp.'s price-to-earnings ratio is -- while Varex Imaging Corp.'s PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix Corp. is 1.85x versus 0.71x for Varex Imaging Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix Corp.
    1.85x -- $40.2M -$33.5M
    VREX
    Varex Imaging Corp.
    0.71x 17.58x $209.6M $2.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
23
CAR alert for Feb 20

Avis Budget Group, Inc. [CAR] is down 0.3% over the past day.

Buy
75
HYMC alert for Feb 20

Hycroft Mining Holding Corp. [HYMC] is down 2.47% over the past day.

Sell
1
EPAM alert for Feb 20

EPAM Systems, Inc. [EPAM] is down 0.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock